Skip to content

CliniMACS PBS/EDTA Buffer 1L 70026Recalls & reported problems

Miltenyi Biotec B.V. & Co. KG · CliniMACS® PBS/EDTA Buffer is a single-use, sterile, isotonic buffer solution used as part of the CliniMACS CD34 Reagent System. The CliniMACS® CD34 Reagent System is an in vitro medical device system used to select and enrich CD34+ cells from HPC, Apheresis while passively depleting other cells, such as CD3+ T cells, which cause graft versus host disease. The system is based on "magnetically-activated cell sorting" (MACS) employing antibodies conjugated to iron-containing particles that can be attracted to a magnetic field (referred to as “magnetic labeling”). Using the specificity of anti-CD34 antibody interaction with cell surface CD34 antigen found on hematopoietic progenitor cells, the system enriches CD34+ cells from HPC, Apheresis by passing the antibody-labeled cell suspension through a separation column with a strong magnetic gradient. The separation column retains the magnetically labeled CD34+ target cells while unlabeled cells flow through and are collected in the Negative Fraction Bag. Several automated washing steps are performed, disposing most of the liquid into the Buffer Waste Bag. The magnetically-selected CD34+ cells are released from the separation column when the magnet is disengaged, removing the magnetic field, and the target CD34+ cells are eluted into the Cell Collection Bag. · Class f

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04049934004674), received between Sep 28, 2015 and Sep 28, 2015 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Rupture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Rupture1

Patient problems

  • No Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 28, 2015Material Rupture

    THE CUSTOMER REPORTED THAT THEY FOUND A SMALL, BLACK AND RUBBER-LIKE FRAGMENT IN ONE OF THEIR CLINIMACS PBS/EDTA BUFFER BAGS 1L, AFTER SPIKING. THE DEBRIS WAS IDENTIFIED PRIOR TO CELL PROCESSING AND THEREFORE THE PATIENTS CELL PROCESSING MATERIAL FOR TRANSPLANTATION WAS NOT AFFECTED. THE SITE HAD A SPARE BUFFER ON HAND THAT WAS USED FOR THE CELL SEPARATION PROCESS. THE CELL SAMPLE WAS ADMINISTERED TO THE PATIENT. BASED ON THE INFORMATION PROVIDED, HARM TO THE PATIENT CAN BE EXCLUDED. THE EVENT HAPPENED AT: (B)(6).

    Patient problems: No Information

    MAUDE report 5108562 ↗

Other Magnetic Cell Selection System For Cd34+ Cells From Hpc-Apheresis Used In Treatment Of Acute Myeloid Leukemia (Aml) devices

All Magnetic Cell Selection System For Cd34+ Cells From Hpc-Apheresis Used In Treatment Of Acute Myeloid Leukemia (Aml) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page